August 06, 2026
Drug testing is evolving, but the goal remains the same: keeping safety-sensitive workplaces safe. Recent industry data continues to show that hair testing identifies significantly more long-term drug use than urine testing alone. At the same time, urine testing remains essential for detecting recent use, supporting post-accident and reasonable suspicion testing, and filling important coverage gaps.
In this 15-minute webinar, we'll review the latest research from DISA, Psychemedics, and other industry sources, including real-world positivity data and national trends. You'll leave with a practical understanding of why leading organizations are moving beyond the "hair versus urine" debate and adopting a dual-methodology approach that delivers broader detection, stronger deterrence, and a more complete safety program.
Key Learnings:
1. Why hair testing consistently identifies more long-term substance use and what the latest industry data reveals.
2. Why urine testing still plays a critical role in recent-use detection, post-accident testing, reasonable suspicion testing, and broader drug panel coverage.
3. How combining hair and urine testing closes detection gaps, strengthens deterrence, and creates a more comprehensive safety program than either methodology alone.
This will be a 15-minute webinar followed by 10 minutes of Q&A.